Transactions
Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa
“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a
Filter By:
“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a
An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern
Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical
Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational
Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan
Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted the
Aspen Pharmacare Holdings Limited (“Aspen”) (Incorporated in the Republic of South Africa) Registration Number 1985/002935/06 Share code APN – ISIN: ZAE000066692 (“Aspen Holdings”) ASPEN ANNOUNCES
Johannesburg. Aspen (APN), South Africa’s leading pharmaceutical company, has announced that Irish-based Tibotec Pharmaceuticals has granted it a non-exclusive license to manufacture, market and distribute
Johannesburg. Aspen (APN), South Africa’s leading pharmaceutical company, has announced that all conditions precedent have been met for it to acquire the pharmaceutical business of
Aspen ARV tender bid is successfulFollowing the announcement of the Anti-Retroviral (ARV) Tender results by the South African National Treasury Department, Aspen Pharmacare Holdings Limited
By : Shauneen Beukes ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN ISIN: ZAE000066692 (“Aspen”) ANNOUNCEMENT
Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN ISIN: ZAE000066692 (“Aspen”) Renewal of detailed cautionary announcement
Aspen Pharmacare Holdings Limited (“Aspen”), listed on the JSE, South Africa (share code APN) and Strides Arcolab Limited, today announced a restructuring of their arrangements
Johannesburg – Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa’s leading pharmaceutical manufacturer, as part of the joint collaboration on
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600
Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com